>
GURUFOCUS.COM > STOCK LIST > Healthcare > Drug Manufacturers > Zoetis Inc (NYSE:ZTS) > Definitions > Operating Margin %
Switch to:

Zoetis Operating Margin %

: 39.73% (As of Mar. 2022)
View and export this data going back to 2013. Start your Free Trial

Operating Margin % is calculated as Operating Income divided by its Revenue. Zoetis's Operating Income for the three months ended in Mar. 2022 was $789 Mil. Zoetis's Revenue for the three months ended in Mar. 2022 was $1,986 Mil. Therefore, Zoetis's Operating Margin % for the quarter that ended in Mar. 2022 was 39.73%.

Good Sign:

Zoetis Inc operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for Zoetis's Operating Margin % or its related term are showing as below:

ZTS' s Operating Margin % Range Over the Past 10 Years
Min: 17.98   Med: 30.41   Max: 36.05
Current: 35.95


ZTS's Operating Margin % is ranked better than
97.07% of 1057 companies
in the Drug Manufacturers industry
Industry Median: 5.41 vs ZTS: 35.95

Zoetis's 5-Year Average Operating Margin % Growth Rate was 3.80% per year.

Zoetis's Operating Income for the three months ended in Mar. 2022 was $789 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2022 was $2,837 Mil.


Zoetis Operating Margin % Historical Data

The historical data trend for Zoetis's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zoetis Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Operating Margin %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.50 32.29 32.24 33.99 36.05

Zoetis Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Operating Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.35 37.17 36.58 30.30 39.73

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zoetis's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Zoetis Operating Margin % Distribution

For the Drug Manufacturers industry and Healthcare sector, Zoetis's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Zoetis's Operating Margin % falls into.



Zoetis Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Zoetis's Operating Margin % for the fiscal year that ended in Dec. 2021 is calculated as

Operating Margin %=Operating Income (A: Dec. 2021 ) / Revenue (A: Dec. 2021 )
=2803 / 7776
=36.05 %

Zoetis's Operating Margin % for the quarter that ended in Mar. 2022 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2022 ) / Revenue (Q: Mar. 2022 )
=789 / 1986
=39.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zoetis  (NYSE:ZTS) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Zoetis Operating Margin % Related Terms

Thank you for viewing the detailed overview of Zoetis's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zoetis Business Description

Zoetis logo
Industry
Healthcare » Drug Manufacturers NAICS : 325412 SIC : 2834
Traded in Other Exchanges
Address
10 Sylvan Way, Parsippany, NJ, USA, 07054
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Executives
Kelly Robert Edward officer: Executive Vice President C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY NJ 07054
Lagano Roxanne officer: Executive Vice President C/O ZOETIS INC. 100 CAMPUS DRIVE FLORHAM PARK NJ 07940
Chen Heidi C. officer: Executive Vice President C/O ZOETIS INC. 100 CAMPUS DRIVE FLORHAM PARK NJ 07940
Knupp Catherine A. officer: Executive Vice President C/O ZOETIS INC. 100 CAMPUS DRIVE FLORHAM PARK NJ 07940
David Glenn officer: Chief Financial Officer C/O ZOETIS INC., 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Nayak Abhay U officer: Senior Vice President C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY NJ 07054
Peck Kristin C director, officer: Chief Executive Officer C/O ZOETIS INC. 100 CAMPUS DRIVE FLORHAM PARK NJ 07940
Bettington Timothy J officer: Executive Vice President C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY NJ 07054
Mamilli Wafaa officer: Executive Vice President C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY NJ 07054
Mcfarland James Michael officer: Executive Vice President C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY NJ 07054
Trawicki Roman officer: Executive Vice President C/O ZOETIS INC. 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Steere William C Jr director 225 LEROY AVENUE DARIEN CT 06820
Rhodes Linda director 56 EVERGREEN DRIVE PORTLAND ME 04103
Reed Willie M director C/O ZOETIS 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Alaix Juan Ramon director C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY NJ 07054

Zoetis Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)